LeMaitre (LMAT) senior VP sells 2,928 shares in open-market trade

Rhea-AI Filing Summary

LeMaitre Vascular Senior Vice President of Operations Trent G. Kamke sold 2,928 shares of Common Stock in an open-market transaction on May 8, 2026. The weighted average sale price was $106.9969 per share, with trades ranging from $105.32 to $107.46. Following this sale, Kamke directly holds 3,749 shares.

Insider Trade Summary

Net Seller: 2,928 shares ($313,287)

Net Sell 1 txn

Insider Kamke Trent G

Role Senior V. P., Operations

Sold 2,928 shs ($313K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,928	$106.9969	$313K

Holdings After Transaction: Common Stock — 3,749 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 2,928 shares Weighted average sale price: $106.9969 per share Post-transaction holdings: 3,749 shares +1 more

4 metrics

Shares sold 2,928 shares Open-market sale of Common Stock on May 8, 2026

Weighted average sale price $106.9969 per share Average price for the 2,928 shares sold

Post-transaction holdings 3,749 shares Direct ownership after the sale

Trade price range $105.32–$107.46 Range of prices for individual trades in the sale

Key Terms

weighted average price, open-market sale, Common Stock, Security and Exchange Commission

4 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Security and Exchange Commission regulatory

"staff of the Securities and Exchange Commission, upon request"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kamke Trent G

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR , INC.

63 SECOND AVENUE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior V. P., Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/08/2026		S		2,928	D	$106.9969(1)	3,749	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $105.32 to $107.46. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

	/s/ Laurie A. Churchill, Attorney-in-fact	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did LeMaitre Vascular (LMAT) report for Trent G. Kamke?

LeMaitre Vascular reported that Senior Vice President of Operations Trent G. Kamke sold 2,928 shares of Common Stock. The transaction was an open-market sale executed on May 8, 2026, as shown in the Form 4 filing.

At what price did Trent G. Kamke sell LeMaitre Vascular (LMAT) shares?

Trent G. Kamke sold the shares at a weighted average price of $106.9969 per share. According to the filing, individual trades occurred in a price range from $105.32 to $107.46 on the transaction date.

How many LeMaitre Vascular (LMAT) shares does Trent G. Kamke hold after the sale?

After the reported sale, Trent G. Kamke directly holds 3,749 shares of LeMaitre Vascular Common Stock. This post-transaction ownership figure is disclosed in the Form 4 as the total shares following the transaction.

What type of transaction was reported in the LeMaitre Vascular (LMAT) Form 4?

The Form 4 describes the activity as an open-market sale of Common Stock. The transaction code is “S,” indicating a sale in the open market or a private transaction, with no derivative securities involved in this filing.

Does the LeMaitre Vascular (LMAT) Form 4 provide details on the trade pricing range?

Yes. A footnote explains the reported price is a weighted average and that individual trades were executed between $105.32 and $107.46. The insider offers to provide full trade-by-trade details upon request to interested parties.